EcoDrugPlus

Erb-B2 Receptor Tyrosine Kinase 3

Ensembl ID : ENSAOCG00000007874
Gene Symbol: ERBB3
3 Cross references
210 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 4

Ensembl ID : ENSAOCG00000017953
Gene Symbol: ERBB4
3 Cross references
222 Possible Orthologues:

Estrogen Receptor

Ensembl ID : ENSAOCG00000015411
Gene Symbol: ARMT1
3 Cross references
215 Possible Orthologues:

Estrogen Receptor Beta

Ensembl ID : ENSAOCG00000022759
Gene Symbol: LOC111588998
3 Cross references
199 Possible Orthologues:

Estrogen Receptor Beta-Like

Ensembl ID : ENSAOCG00000018453
Gene Symbol: LOC111586778
3 Cross references
172 Possible Orthologues:

Estrogen-Related Receptor Gamma

Ensembl ID : ENSAOCG00000003655
Gene Symbol: LOC111562671
3 Cross references
203 Possible Orthologues:

Exportin 1

Ensembl ID : ENSAOCG00000018914
Gene Symbol: XPO1
3 Cross references
229 Possible Orthologues:

Exportin 1

Ensembl ID : ENSAOCG00000010121
Gene Symbol: XPO1
3 Cross references
217 Possible Orthologues:

Farnesyl Pyrophosphate Synthase-Like

Ensembl ID : ENSAOCG00000012524
Gene Symbol: LOC111571978
3 Cross references
269 Possible Orthologues:

Farnesyl-Diphosphate Farnesyltransferase 1

Ensembl ID : ENSAOCG00000015903
Gene Symbol: FDFT1
3 Cross references
221 Possible Orthologues:

Fibroblast Growth Factor Receptor 1-A-Like

Ensembl ID : ENSAOCG00000012956
Gene Symbol: LOC111586930
2 Cross references
201 Possible Orthologues:

Fibroblast Growth Factor Receptor 1-A-Like

Ensembl ID : ENSAOCG00000016923
Gene Symbol: LOC111571065
4 Cross references
208 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).